Epoch Investment Partners’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-30,169
Closed -$816K 388
2024
Q3
$816K Hold
30,169
﹤0.01% 312
2024
Q2
$752K Buy
30,169
+647
+2% +$18.6K ﹤0.01% 324
2024
Q1
$980K Sell
29,522
-1,950
-6% -$66.6K ﹤0.01% 334
2023
Q4
$1.12M Buy
31,472
+2,150
+7% +$68.2K 0.01% 340
2023
Q3
$1M Buy
29,322
+2,800
+11% +$106K 0.01% 345
2023
Q2
$1.06M Sell
26,522
-1,780
-6% -$70.8K 0.01% 358
2023
Q1
$1.11M Sell
28,302
-20
-0.1% -$734 0.01% 349
2022
Q4
$902K Buy
28,322
+2,610
+10% +$78.7K 0.01% 351
2022
Q3
$729K Sell
25,712
-304
-1% -$10.4K ﹤0.01% 365
2022
Q2
$930K Buy
26,016
+3,950
+18% +$160K 0.01% 359
2022
Q1
$1.09M Buy
+22,066
New +$1.17M 0.01% 364
2017
Q4
Sell
-1,738,029
Closed -$104M 318
2017
Q3
$104M Sell
1,738,029
-1,947,975
-53% -$116M 0.35% 92
2017
Q2
$239M Buy
3,686,004
+123,668
+3% +$7.81M 0.81% 42
2017
Q1
$222M Sell
3,562,336
-258,661
-7% -$15.6M 0.74% 51
2016
Q4
$221M Buy
3,820,997
+2,620,098
+218% +$155M 0.83% 46
2016
Q3
$71.4M Buy
+1,200,899
New +$73.8M 0.27% 99

Other funds holding XRAY

Epoch Investment Partners's XRAY Position: Q4 2024 in Review

Epoch Investment Partners sold out of Dentsply Sirona (XRAY) in Q4 2024, closing a stake of 30,169 shares — an estimated $816K sold.

Epoch Investment Partners first reported a position in XRAY in Q3 2016 and held it in 16 quarters. The position peaked at $239M in Q2 2017. 359 funds tracked by Wall St. Rank hold XRAY as of Q4 2024.

  • Epoch Investment Partners reported no remaining Dentsply Sirona position as of Q4 2024 after selling out during the quarter.
  • Epoch Investment Partners sold 30,169 Dentsply Sirona shares in Q4 2024, an estimated $816K.
  • Epoch Investment Partners first reported a position in Dentsply Sirona in Q3 2016 and held it in 16 quarters.
  • Epoch Investment Partners's Dentsply Sirona position peaked at $239M in Q2 2017.
  • 359 funds tracked by Wall St. Rank held Dentsply Sirona as of Q4 2024.

Based on Epoch Investment Partners's 13F filing for Q4 2024, filed 13 Feb 2025.